These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
794 related articles for article (PubMed ID: 21154355)
1. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals. Mbuagbaw LC; Irlam JH; Spaulding A; Rutherford GW; Siegfried N Cochrane Database Syst Rev; 2010 Dec; (12):CD004246. PubMed ID: 21154355 [TBL] [Abstract][Full Text] [Related]
2. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals. Mbuagbaw L; Mursleen S; Irlam JH; Spaulding AB; Rutherford GW; Siegfried N Cochrane Database Syst Rev; 2016 Dec; 12(12):CD004246. PubMed ID: 27943261 [TBL] [Abstract][Full Text] [Related]
3. Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals. Spaulding A; Rutherford GW; Siegfried N Cochrane Database Syst Rev; 2010 Oct; (10):CD008740. PubMed ID: 20927777 [TBL] [Abstract][Full Text] [Related]
4. Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individuals. Spaulding A; Rutherford GW; Siegfried N Cochrane Database Syst Rev; 2010 Aug; (8):CD008651. PubMed ID: 20687097 [TBL] [Abstract][Full Text] [Related]
5. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV. Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD008270. PubMed ID: 23740608 [TBL] [Abstract][Full Text] [Related]
6. Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy. Humphreys EH; Hernandez LB; Rutherford GW Cochrane Database Syst Rev; 2007 Oct; (4):CD006517. PubMed ID: 17943914 [TBL] [Abstract][Full Text] [Related]
7. Nevirapine or efavirenz combined with two nucleoside reverse transcriptase inhibitors compared to HAART: a meta-analysis of randomized clinical trials. Torre D; Tambini R; Speranza F HIV Clin Trials; 2001; 2(2):113-21. PubMed ID: 11590519 [TBL] [Abstract][Full Text] [Related]
8. Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults. Siegfried NL; Van Deventer PJ; Mahomed FA; Rutherford GW Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD004535. PubMed ID: 16625606 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children. Lapphra K; Vanprapar N; Chearskul S; Phongsamart W; Chearskul P; Prasitsuebsai W; Chokephaibulkit K Int J Infect Dis; 2008 Nov; 12(6):e33-8. PubMed ID: 18573672 [TBL] [Abstract][Full Text] [Related]
10. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age. Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077 [TBL] [Abstract][Full Text] [Related]
11. Comparative durability of nevirapine versus efavirenz in first-line regimens during the first year of initiating antiretroviral therapy among Swaziland HIV-infected adults. Takuva S; Evans D; Zuma K; Okello V; Louwagie G Pan Afr Med J; 2013; 15():5. PubMed ID: 23847702 [TBL] [Abstract][Full Text] [Related]
12. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Siegfried N; van der Merwe L; Brocklehurst P; Sint TT Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394 [TBL] [Abstract][Full Text] [Related]
13. Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study. Mwesigire DM; Wu AW; Martin F; Katamba A; Seeley J BMC Health Serv Res; 2015 Jul; 15():292. PubMed ID: 26216221 [TBL] [Abstract][Full Text] [Related]
14. Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy. Humphreys EH; Chang LW; Harris J Cochrane Database Syst Rev; 2010 Jun; (6):CD006517. PubMed ID: 20556768 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age. Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492 [TBL] [Abstract][Full Text] [Related]
16. Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons. van den Berg-Wolf M; Hullsiek KH; Peng G; Kozal MJ; Novak RM; Chen L; Crane LR; Macarthur RD; HIV Clin Trials; 2008; 9(5):324-36. PubMed ID: 18977721 [TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and tolerance of efavirenz- and nevirapine-containing regimens in adult HIV type 1 Senegalese patients. de Beaudrap P; Etard JF; Guèye FN; Guèye M; Landman R; Girard PM; Sow PS; Ndoye I; Delaporte E; AIDS Res Hum Retroviruses; 2008 Jun; 24(6):753-60. PubMed ID: 18507521 [TBL] [Abstract][Full Text] [Related]
18. Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA. Bannister WP; Ruiz L; Cozzi-Lepri A; Mocroft A; Kirk O; Staszewski S; Loveday C; Karlsson A; Monforte Ad; Clotet B; Lundgren JD; AIDS; 2008 Jan; 22(3):367-76. PubMed ID: 18195563 [TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Sturt AS; Dokubo EK; Sint TT Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370 [TBL] [Abstract][Full Text] [Related]
20. Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a longitudinal cohort study. Chendi BH; Okomo Assoumou MC; Jacobs GB; Yekwa EL; Lyonga E; Mesembe M; Eyoh A; Ikomey GM BMC Infect Dis; 2019 Feb; 19(1):194. PubMed ID: 30808298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]